본문 바로가기
KERD
논문KCI 등재

Disease model organism for Parkinson disease: Drosophila melanogaster

이영석|Binod Aryal
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2019.04|BMB Reports|제52권 제4호|pp. 250-258|DOI https://doi.org/10.5483/BMBRep.2019.52.4.204

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

Parkinson’s diseaseOxidative stressMitochondrial dysfunctionEnvironmental toxinsGenetic factors
주제분류화학

초록

Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by selective and progressive loss of dopaminergic neurons. Genetic and environmental risk factors are associated with this disease. The genetic factors are composed of approximately 20 genes, such as SNCA, parkin, PTEN-induced kinase1 (pink1), leucine-rich repeat kinase 2 (LRRK2), ATP13A2, MAPT, VPS35, and DJ-1, whereas the environmental factors consist of oxidative stress-induced toxins such as 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP), rotenone, and paraquat. The analyses of their functions and mechanisms have provided important insights into the disease process, which has demonstrated that these factors cause oxidative damage and mitochondrial dysfunction. The most invaluable studies have been performed using disease model organisms, such as mice, fruit flies, and worms. Among them, Drosophila melanogaster has emerged as an excellent model organism to study both environmental and genetic factors and provide insights to the pathways relevant for PD pathogenesis, facilitating development of therapeutic strategies. In this review, we have focused on the fly model organism to summarize recent progress, including pathogenesis, neuroprotective compounds, and newer approaches.

Abstract

Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by selective and progressive loss of dopaminergic neurons. Genetic and environmental risk factors are associated with this disease. The genetic factors are composed of approximately 20 genes, such as SNCA, parkin, PTEN-induced kinase1 (pink1), leucine-rich repeat kinase 2 (LRRK2), ATP13A2, MAPT, VPS35, and DJ-1, whereas the environmental factors consist of oxidative stress-induced toxins such as 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP), rotenone, and paraquat. The analyses of their functions and mechanisms have provided important insights into the disease process, which has demonstrated that these factors cause oxidative damage and mitochondrial dysfunction. The most invaluable studies have been performed using disease model organisms, such as mice, fruit flies, and worms. Among them, Drosophila melanogaster has emerged as an excellent model organism to study both environmental and genetic factors and provide insights to the pathways relevant for PD pathogenesis, facilitating development of therapeutic strategies. In this review, we have focused on the fly model organism to summarize recent progress, including pathogenesis, neuroprotective compounds, and newer approaches.

참고문헌 (99)

  1. Forno LS, "Neuropathology of Parkinson's disease", J Neuropathol Exp Neurol, 55, pp.259~272 (1996)
  2. Whitton P, "Inflammation as a causative factor in the aetiology of Parkinson's disease", Br J Pharmacol, 150, pp.963~976 (2007)
  3. Polymeropoulos MH, "Mutation in the α-synuclein gene identified in families with Parkinson's disease", Science, 276, pp.2045~2047 (1997)
  4. Singleton A, "α-Synuclein locus triplication causes Parkinson's disease", Science, 302, pp.841~841 (2003)
  5. Zimprich A, "Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology", Neuron, 44, pp.601~607 (2004)
  6. Zimprich A, "A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease", Am J Hum Genet, 89, pp.168~175 (2011)
  7. Wakabayashi K, "Pathology of familial Parkinson's disease", Brain Nerve, 59, pp.851~864 (2007)
  8. Chartier-Harlin M-C, "Translation initiator EIF4G1 mutations in familial Parkinson disease", Am J Hum Genet, 89, pp.398~406 (2011)
  9. Kitada T, "Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism", Nature, 392, pp.605~608 (1998)
  10. Bonifati V, "DJ-1(PARK7), a novel gene for autosomal recessive, early onset parkinsonism", Neurol Sci, 24, pp.159~160 (2003)
  11. Valente EM, "Hereditary early-onset Parkinson's disease caused by mutations in PINK1", Science, 304, pp.1158~1160 (2004)
  12. Köroğlu Ç, "DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability", Parkinsonism Relat Disord, 19, pp.320~324 (2013)
  13. Quadri M, "Mutation in the SYNJ1 Gene Associated with Autosomal Recessive, Early‐Onset P arkinsonism", Hum Mutat, 34, pp.1208~1215 (2013)
  14. Ramirez A, "Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5P-type ATPase", Nat Genet, 38, pp.1184~1190 (2006)
  15. Greenamyre JT, "Parkinson's--divergent causes, convergent mechanisms", Science, 304, pp.1120~1122 (2004)
  16. Bilen J, "Drosophila as a model for human neurodegenerative disease", Annu Rev Genet, 39, pp.153~171 (2005)
  17. Feany MB, "A Drosophila model of Parkinson's disease", Nature, 404, pp.394~398 (2000)
  18. Pareek G, "Loss of the Drosophila m-AAA mitochondrial protease paraplegin results in mitochondrial dysfunction, shortened lifespan, and neuronal and muscular degeneration", Cell Death Dis, 9, pp.304~ (2018)
  19. Kroemer G, "Mitochondrial membrane permeabilization in cell death", Physiol Rev, 87, pp.99~163 (2007)
  20. Kann O, "Mitochondria and neuronal activity", Am J Physiol Cell Physiol, 292, pp.C641~C657 (2007)[DOI]
  21. Mosharov EV, "Interplay between cytosolic dopamine, calcium, and α-synuclein causes selective death of substantia nigra neurons", Neuron, 62, pp.218~229 (2009)
  22. Dehay B, "Targeting α-synuclein for treatment of Parkinson's disease:mechanistic and therapeutic considerations", Lancet Neurol, 14, pp.855~866 (2015)
  23. Blum D, "Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP : contribution to the apoptotic theory in Parkinson's disease", Prog Neurobiol, 65, pp.135~172 (2001)
  24. Perier C, "Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease", Proc Natl Acad Sci U S A, 104, pp.8161~8166 (2007)
  25. Abou-Sleiman PM, "Expanding insights of mitochondrial dysfunction in Parkinson's disease", Nat Rev Neurosci, 7, pp.207~219 (2006)
  26. Trushina E, "Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases", Neuroscience, 145, pp.1233~1248 (2007)
  27. Blesa J, "Parkinson’s disease : animal models and dopaminergic cell vulnerability", Front Neuroanat, 8, pp.155~ (2014)
  28. Mizuno Y, "Effects of 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine and 1‐methyl‐4‐phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain", J Neurochem, 48, pp.1787~1793 (1987)[DOI]
  29. Betarbet R, "Chronic systemic pesticide exposure reproduces features of Parkinson's disease", Nat Neurosci, 3, pp.1301~1306 (2000)
  30. Lee K-S, "Altered ER–mitochondria contact impacts mitochondria calcium homeostasis and contributes to neurodegeneration in vivo in disease models", Proc Natl Acad Sci U S A, 115, pp.E8844~E8853 (2018)[DOI]
  31. Norris KL, "Convergence of parkin, PINK1 and α-synuclein on stress-induced mitochondrial morphological remodelling", J Neurochem, 290, pp.13862~13874 (2015)
  32. Ludtmann MH, "α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease", Nat Commun, 9, pp.2293~ (2018)
  33. Blandini F, "Animal models of Parkinson’s disease", FEBS J, 279, pp.1156~1166 (2012)
  34. Chen AY, "Olfactory deficits in an alpha-synuclein fly model of Parkinson’s disease", PLoS One, 9, pp.e97758~ (2014)
  35. Khair A, "Silencing of Glucocerebrosidase Gene in Drosophila Enhances the Aggregation of Parkinson's Disease Associated α-Synuclein Mutant A53T and Affects Locomotor Activity", Front Neurosci, 12, pp.81~ (2018)
  36. Davis MY, "Glucocerebrosidase deficiency in Drosophila results in α-synucleinindependent protein aggregation and neurodegeneration", PLoS Genet, 12, pp.e1005944~ (2016)
  37. Miura E, "VPS35dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease", Neurobiol Dis, 71, pp.1~13 (2014)
  38. Suzuki M, "Glucocerebrosidase deficiency accelerates the accumulation of proteinase K-resistant α-synuclein and aggravates neurodegeneration in a Drosophila model of Parkinson's disease", Hum Mol Genet, 24, pp.6675~6686 (2015)
  39. Devi L, "Mitochondrial import and accumulation of α-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain", J Biol Chem, 283, pp.9089~9100 (2008)
  40. Greene JC, "Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants", Proc Natl Acad Sci U S A, 100, pp.4078~4083 (2003)
  41. Park J, "Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction", Gene, 361, pp.133~139 (2005)
  42. Cha G-H, "Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila", Proc Natl Acad Sci U S A, 102, pp.10345~10350 (2005)
  43. Yang Y, "Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1is rescued by Parkin", Proc Natl Acad Sci U S A, 103, pp.10793~10798 (2006)
  44. Lehmann S, "Folinic acid is neuroprotective in a fly model of Parkinson’s disease associated with pink1mutations", Matters, 3, pp.e201702000009~ (2017)
  45. Moisoi N, "Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress", Neuropharmacology, 77, pp.350~357 (2014)
  46. Clark IE, "Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin", Nature, 441, pp.1162~ (2006)
  47. Park J, "Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin", Nature, 441, pp.1157~ (2006)
  48. Clark IE, "Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin", Nature, 441, pp.1162~1166 (2006)
  49. Narendra D, "Parkin is recruited selectively to impaired mitochondria and promotes their autophagy", J Cell Biol, 183, pp.795~803 (2008)
  50. Kim Y, "PINK1 controls mitochondrial localization of Parkin through direct phosphorylation", Biochem Biophys Res Commun, 377, pp.975~980 (2008)
  51. Hayashi T, "DJ-1binds to mitochondrial complex I and maintains its activity", Biochem Biophys Res Commun, 390, pp.667~672 (2009)
  52. Zhang L, "Mitochondrial localization of the Parkinson's disease related protein DJ-1 : implications for pathogenesis", Hum Mol Genet, 14, pp.2063~2073 (2005)
  53. Heo JY, "DJ-1 null dopaminergic neuronal cells exhibit defects in mitochondrial function and structure : involvement of mitochondrial complex I assembly", PLoS One, 7, pp.e32629~ (2012)
  54. Lucas JI, "A new evolutionary paradigm for the Parkinson disease gene DJ-1", Mol Biol Evol, 24, pp.551~561 (2006)
  55. Menzies FM, "Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress", Curr Biol, 15, pp.1578~1582 (2005)
  56. Meulener M, "Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson’s disease", Curr Biol, 15, pp.1572~1577 (2005)
  57. Irrcher I, "Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics", Hum Mol Genet, 19, pp.3734~3746 (2010)
  58. Meulener MC, "Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging", Proc Natl Acad Sci U S A, 103, pp.12517~12522 (2006)
  59. seeta poudel, "Impaired Taste Associative Memory and Memory Enhancement by Feeding Omija in Parkinson’s Disease Fly Model", Molecules and Cells, 41(7), pp.646~652 (2018), 한국분자세포생물학회
  60. Wallings R, "Cellular processes associated with LRRK2 function and dysfunction", FEBS J, 282, pp.2806~2826 (2015)
  61. Karuppagounder SS, "LRRK2G2019S transgenic mice display increased susceptibility to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-mediated neurotoxicity", J Chem Neuroanat, 76, pp.90~97 (2016)[DOI]
  62. Liu Z, "A Drosophila model for LRRK2-linked parkinsonism", Proc Natl Acad Sci U S A, 105, pp.2693~2698 (2008)
  63. Yang D, "Drosophila hep pathway mediates Lrrk2-induced neurodegeneration", Biochem Cell Biol, 96, pp.441~449 (2017)
  64. Schober A, "Classic toxin-induced animal models of Parkinson’s disease : 6-OHDA and MPTP", Cell Tissues Res, 318, pp.215~224 (2004)
  65. Tieu K, "A guide to neurotoxic animal models of Parkinson’s disease", Cold Spring Harb Perspect Med, 1, pp.a009316~ (2011)
  66. Abolaji AO, "Resveratrol prolongs lifespan and improves 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridineinduced oxidative damage and behavioural deficits in Drosophila melanogaster", Biochem Biophys Res Commun, 503, pp.1042~1048 (2018)[DOI]
  67. Trinh K, "Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson's disease through an NRF2-dependent mechanism", J Neurosci, 30, pp.5525~5532 (2010)
  68. Srivastava P, "Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding", FEBS J, 274, pp.4788~4801 (2007)
  69. Sherer TB, "Mechanism of toxicity in rotenone models of Parkinson's disease", J Neurosci, 23, pp.10756~10764 (2003)
  70. Vos M, "Vitamin K2is a mitochondrial electron carrier that rescues pink1deficiency", Science, 336, pp.1306~1310 (2012)
  71. Mena MA, "Half a century of L-DOPA", Curr Top Med Chem, 9, pp.880~893 (2009)
  72. Payami H, "Promise of pharmacogenomics for drug discovery, treatment and prevention of Parkinson’s disease. A perspective", Neurotherapeutics, 11, pp.111~116 (2014)
  73. Saini N, "Zinc supplement greatly improves the condition of parkin mutant Drosophila", Biol Chem, 391, pp.513~518 (2010)
  74. Guo J, "Piperine ameliorates SCA17 neuropathology by reducing ER stress", Mol Neurodegener, 13, pp.4~ (2018)
  75. Lee MK, "Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53→ Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice", Proc Natl Acad Sci U S A, 99, pp.8968~8973 (2002)
  76. Dalfo E, "Abnormal α-synuclein interactions with Rab proteins in α-synuclein A30P transgenic mice", J Neuropathol Exp Neuron, 63, pp.302~313 (2004)
  77. Lu X-H, "Bacterial artificial chromosome transgenic mice expressing a truncated mutant Parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant α-synuclein", J Neurosci, 29, pp.1962~1976 (2009)
  78. Gasser T, "Genetics of Parkinson's disease", J neurol, 248, pp.833~840 (2001)
  79. Kumar R, "S-nitrosylation of UCHL1 induces its structural instability and promotes α-synuclein aggregation", Sci Rep, 7, pp.44558~ (2017)
  80. Tran HH, "Drosophila Ubiquitin C-Terminal Hydrolase Knockdown Model of Parkinson’s Disease", Sci Rep, 8, pp.4468~ (2018)
  81. Kelm-Nelson CA, "Characterization of early-onset motor deficits in the Pink1−", − mouse model of Parkinson disease, 2018, pp.1680, 1~12
  82. Cornelissen T, "Deficiency of parkin and PINK1 impairs age-dependent mitophagy in Drosophila", eLife, 7, pp.e35878~ (2018)
  83. Rousseaux MW, "Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease", Proc Natl Acad Sci U S A, 109, pp.15918~15923 (2012)
  84. Li Y, "Mutant LRRK2 R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease", Nat Neurosci, 12, pp.826~828 (2009)
  85. Usenovic M, "Deficiency of ATP13A2 leads to lysosomal dysfunction, α-synuclein accumulation, and neurotoxicity", J Neurosci, 32, pp.4240~4246 (2012)
  86. Giovannone B, "GIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signaling", Hum Mol Genet, 18, pp.4629~4639 (2009)
  87. Kim M, "Drosophila Gyf", GRB10 interacting GYF protein is an autophagy regulator that controls neuron and muscle homeostasis, 2015, pp.11, 1358~1372
  88. Martins LM, "Neuroprotective role of the Reaper-related serine protease HtrA2", Omi revealed by targeted deletion in mice, 2004, pp.24, 9848~9862
  89. Tain LS, "Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin", Cell Death Differ, 16, pp.1118~1125 (2009)
  90. Zhou Q, "Impairment of PARK14-dependent Ca 2+ signalling is a novel determinant of Parkinson’s disease", Nat Commun, 7, pp.10332~ (2016)
  91. Chiu C-C, "PARK14 PLA2G6mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway", Oncotarget, 8, pp.79046~79060 (2017)
  92. Vingill S, "Loss of FBXO7(PARK15)results in reduced proteasome activity and models a parkinsonism‐like phenotype in mice", EMBO J, 35, pp.2008~2025 (2016)
  93. Burchell VS, "The Parkinson's disease–linked proteins Fbxo7 and Parkin interact to mediate mitophagy", Nat Neurosci, 16, pp.1257~1265 (2013)
  94. MacLeod DA, "RAB7L1interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson’s disease risk", Neuron, 77, pp.425~439 (2013)
  95. Tang F-L, "VPS35 deficiency or mutation causes dopaminergic neuronal loss by impairing mitochondrial fusion and function", Cell Rep, 12, pp.1631~1643 (2015)
  96. Yim Y-I, "Endocytosis and clathrin-uncoating defects at synapses of auxilin knockout mice", Proc Natl Acad Sci U S A, 107, pp.4412~4417 (2010)
  97. Song L, "Auxilin underlies progressive locomotor deficits and dopaminergic neuron loss in a Drosophila model of Parkinson’s disease", Cell Rep, 18, pp.1132~1143 (2017)
  98. Pan P-Y, "Parkinson’s Disease-Associated LRRK2 Hyperactive Kinase mutant Disrupts Synaptic Vesicle Trafficking in Ventral midbrain Neurons", J Neurosci, 47, pp.11366~11376 (2017)
  99. Schulze KL, "Genetic and electrophysiological studies of Drosophila syntaxin-1A demonstrate its role in nonneuronal secretion and neurotransmission", Cell, 80, pp.311~320 (1995)

관련 논문AI추천

Presynaptic Dysfunction by Familial Factors in Parkinson Disease고솔미, 김성현, 이원경, 황순도대한배뇨장애요실금학회 · International Neurourology Journal2018 · 제22권 제1호파킨슨병의 원인유전자와 연관된 자가포식현상서혜명, 설원기, 손일홍, 호동환대한신경과학회 · 대한신경과학회지2014 · 제32권 제3호Poly (ADP-ribose) in the pathogenesis of Parkinson's disease강호철, 김영필, 신주호, 이병대, 이연종, 이윤일생화학분자생물학회 · BMB Reports2014 · 제47권 제8호The role of neuroinflammation on the pathogenesis of Parkinson’s disease고혁완, 남진한, 복유진, 정영철, 진병관, 허수희생화학분자생물학회 · BMB Reports2010 · 제43권 제4호Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson’s disease설원기생화학분자생물학회 · BMB Reports2010 · 제43권 제4호LRRK2 and membrane trafficking: nexus of Parkinson's disease이병대, 장은해, 정가람, 허은미생화학분자생물학회 · BMB Reports2019 · 제52권 제9호

이 간행물의 다른 논문 (8건)

Biological roles and an evolutionary sketch of the GRF-GIF transcriptional complex in plants김정회pp. 227-238Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinaseLeslie Duplaquet, Marie Fernandes, David Tulasnepp. 239-249Human umbilical cord blood plasma alleviates age-related olfactory dysfunction by attenuating peripheral TNF-α expression신나리, 이진영, 이승은, 강경선, 김재준, 강인성, 최순원, 이병철pp. 259-264Defect of SIRT1-FoxO3a axis is associated with the production of reactive oxygen species during protein kinase CK2 downregulation-mediated cellular senescence and nematode aging박정우, 배영석, 함혜준pp. 265-270Renal protective effects of zingerone in a mouse model of sepsis구세광, 이창훈, 양수민, 배종섭, 이봉선pp. 271-276
원문 보기